NFE2L2 and hepatocellular carcinoma: In doxorubicin resistant HCC BEL-7402/ADM cells, chrysin could significantly enhance their sensitivity to doxorubicin via inhibiting Nrf2 expression and downregulating the downstream genes such as HO-1, AKR1B10 and MRP5 63.